• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠体内人天然的、与蛋白酶复合的以及经蛋白水解失活的C1抑制因子的清除情况。

Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats.

作者信息

de Smet B J, de Boer J P, Agterberg J, Rigter G, Bleeker W K, Hack C E

机构信息

Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam.

出版信息

Blood. 1993 Jan 1;81(1):56-61.

PMID:8417802
Abstract

C1-inhibitor is the only known inhibitor of the classical pathway of complement and the major inhibitor of the contact pathway of coagulation. Like other serine proteinase inhibitors, C1-inhibitor can exist in three conformations, ie, the native, the proteinase-complexed, and the proteolytically inactivated form. Here we studied the plasma elimination kinetics of these three forms of human C1-inhibitor in rats. The clearance of the complexed form of C1-inhibitor appeared to be the most rapid and depended in part on the proteinase involved (observed plasma t1/2 was 20 minutes for C1s-C1-inhibitor, 32 minutes for kallikrein-C1-inhibitor, and 47 minutes for beta XIIa-C1-inhibitor), whereas that of native C1-inhibitor was the slowest (observed plasma t1/2 4.5 hours). Inactivated C1-inhibitor was cleared with an apparent plasma t1/2 of 1.6 hours. Thus, the short plasma t1/2 of complexed relative to native C1-inhibitor explains why in patients only low concentrations of C1-inhibitor complexes may be observed despite activation of the contact and/or complement systems.

摘要

C1抑制剂是补体经典途径唯一已知的抑制剂以及凝血接触途径的主要抑制剂。与其他丝氨酸蛋白酶抑制剂一样,C1抑制剂可以以三种构象存在,即天然构象、与蛋白酶复合的构象和蛋白水解失活形式。在此,我们研究了这三种形式的人C1抑制剂在大鼠体内的血浆清除动力学。C1抑制剂复合形式的清除似乎最快,部分取决于所涉及的蛋白酶(观察到的血浆半衰期,C1s-C1抑制剂为20分钟,激肽释放酶-C1抑制剂为32分钟,β XIIa-C1抑制剂为47分钟),而天然C1抑制剂的清除最慢(观察到的血浆半衰期为4.5小时)。失活的C1抑制剂以1.6小时的表观血浆半衰期被清除。因此,与天然C1抑制剂相比,复合形式的血浆半衰期较短,这就解释了为什么在患者中尽管接触和/或补体系统被激活,但可能仅观察到低浓度的C1抑制剂复合物。

相似文献

1
Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats.大鼠体内人天然的、与蛋白酶复合的以及经蛋白水解失活的C1抑制因子的清除情况。
Blood. 1993 Jan 1;81(1):56-61.
2
The catabolism of intact, reactive centre-cleaved and proteinase-complexed C1 inhibitor in the guinea pig.豚鼠体内完整的、反应中心裂解的和与蛋白酶复合的C1抑制剂的分解代谢
Clin Exp Immunol. 1996 Jul;105(1):191-7. doi: 10.1046/j.1365-2249.1996.d01-714.x.
3
Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils.重组C1抑制剂P5/P3变体对受刺激的中性粒细胞催化失活具有抗性。
J Clin Invest. 1993 Mar;91(3):1035-43. doi: 10.1172/JCI116260.
4
A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.当C1抑制剂的反应中心被血浆激肽释放酶、活化的因子XII片段、C1酯酶或中性粒细胞弹性蛋白酶切割时,会产生一种常见的新表位。
J Clin Invest. 1988 Aug;82(2):700-5. doi: 10.1172/JCI113650.
5
C1-inhibitor polymers activate the FXII-dependent kallikrein-kinin system: Implication for a role in hereditary angioedema.C1抑制剂聚合物激活依赖于FXII的激肽释放酶-激肽系统:对遗传性血管性水肿作用的启示。
Biochim Biophys Acta. 2015 Jun;1850(6):1336-42. doi: 10.1016/j.bbagen.2015.03.005. Epub 2015 Mar 20.
6
The effect of cleavage by a Crotalus atrox alpha-proteinase fraction on the properties of C1-inhibitor.矛头蝮α蛋白酶组分切割对C1抑制因子特性的影响
Toxicon. 1995 Jan;33(1):53-61. doi: 10.1016/0041-0101(95)93621-z.
7
Biological activities of C1 inhibitor.C1抑制剂的生物学活性。
Mol Immunol. 2008 Oct;45(16):4057-63. doi: 10.1016/j.molimm.2008.06.028. Epub 2008 Jul 31.
8
alpha(1)-Proteinase inhibitor mutants with specificity for plasma kallikrein and C1s but not C1.对血浆激肽释放酶和C1s具有特异性但对C1无特异性的α(1)-蛋白酶抑制剂突变体。
Protein Sci. 2002 Sep;11(9):2230-6. doi: 10.1110/ps.0207302.
9
Expression of functional human C1 inhibitor in COS cells.功能性人C1抑制剂在COS细胞中的表达。
J Biol Chem. 1988 Aug 25;263(24):11776-9.
10
Relative contribution of contact and complement activation to inflammatory reactions in arthritic joints.接触和补体激活在关节炎关节炎症反应中的相对作用。
Ann Rheum Dis. 1992 Oct;51(10):1123-8. doi: 10.1136/ard.51.10.1123.

引用本文的文献

1
C1 esterase inhibitor-mediated immunosuppression in COVID-19: Friend or foe?C1酯酶抑制剂介导的新型冠状病毒肺炎免疫抑制:是友还是敌?
Clin Immunol Commun. 2022 Dec;2:83-90. doi: 10.1016/j.clicom.2022.05.001. Epub 2022 May 5.
2
Pulmonary Procoagulant and Innate Immune Responses in Critically Ill COVID-19 Patients.危重症 COVID-19 患者的肺部促凝和固有免疫反应。
Front Immunol. 2021 May 14;12:664209. doi: 10.3389/fimmu.2021.664209. eCollection 2021.
3
Patterns of C1-Inhibitor/Plasma Serine Protease Complexes in Healthy Humans and in Hereditary Angioedema Patients.
健康人群和遗传性血管性水肿患者中 C1 抑制剂/血浆丝氨酸蛋白酶复合物的模式。
Front Immunol. 2020 May 5;11:794. doi: 10.3389/fimmu.2020.00794. eCollection 2020.
4
Early treatment with C1 esterase inhibitor improves weight but not memory deficits in a rat model of status epilepticus.在癫痫持续状态大鼠模型中,早期使用C1酯酶抑制剂可改善体重,但不能改善记忆缺陷。
Physiol Behav. 2019 Dec 1;212:112705. doi: 10.1016/j.physbeh.2019.112705. Epub 2019 Oct 16.
5
Intermittent C1-Inhibitor Deficiency Associated with Recessive Inheritance: Functional and Structural Insight.间歇性 C1 抑制剂缺乏症与隐性遗传相关:功能和结构见解。
Sci Rep. 2018 Jan 17;8(1):977. doi: 10.1038/s41598-017-16667-w.
6
DNA and factor VII-activating protease protect against the cytotoxicity of histones.DNA和因子VII激活蛋白酶可抵御组蛋白的细胞毒性。
Blood Adv. 2017 Nov 30;1(26):2491-2502. doi: 10.1182/bloodadvances.2017010959. eCollection 2017 Dec 12.
7
Human plasma-derived C1 esterase inhibitor concentrate has limited effect on house dust mite-induced allergic lung inflammation in mice.人血浆源性C1酯酶抑制剂浓缩物对屋尘螨诱导的小鼠过敏性肺部炎症作用有限。
PLoS One. 2017 Oct 16;12(10):e0186652. doi: 10.1371/journal.pone.0186652. eCollection 2017.
8
Ongoing contact activation in patients with hereditary angioedema.遗传性血管性水肿患者的持续接触激活。
PLoS One. 2013 Aug 27;8(8):e74043. doi: 10.1371/journal.pone.0074043. eCollection 2013.
9
Specificity of binding of the low density lipoprotein receptor-related protein to different conformational states of the clade E serpins plasminogen activator inhibitor-1 and proteinase nexin-1.低密度脂蛋白受体相关蛋白与E族丝氨酸蛋白酶抑制剂纤溶酶原激活物抑制剂-1和蛋白酶连接蛋白-1不同构象状态的结合特异性。
J Biol Chem. 2009 Jul 3;284(27):17989-97. doi: 10.1074/jbc.M109.009530. Epub 2009 May 13.
10
Soluble complement receptor 1 protects the peripheral nerve from early axon loss after injury.可溶性补体受体1可保护外周神经免受损伤后早期轴突损失。
Am J Pathol. 2008 Apr;172(4):1043-52. doi: 10.2353/ajpath.2008.070660. Epub 2008 Mar 18.